Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis

被引:375
作者
Adya, Raghu [1 ]
Tan, Bee K. [1 ]
Punn, Anu [1 ]
Chen, Jing [1 ]
Randeva, Harpal S. [1 ]
机构
[1] Univ Warwick, Warwick Med Sch, Clin Sci Res Inst, Endocrinol & Metab Grp, Coventry CV4 7AL, W Midlands, England
关键词
matrix metalloproteinases; VEGF; MAPK; PI3K/Akt; endothelial factors; visfatin;
D O I
10.1093/cvr/cvm111
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims Visfatin is a novel adipokine whose plasma concentrations are altered in obesity and obesity-related disorders; these states are associated with an increased incidence of cardiovascular disease. We therefore investigated the effect of visfatin on vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMP-2, MMP-9) production and the potential signalling cascades. Methods and results In human umbilical vein endothelial cells (HUVECs), visfatin significantly and dose-dependently up-regulated gene expression and protein production of VEGF and MMPS and down-regulated expression of tissue inhibitors of MMPs (TIMP-1 and TIMP-2). The gelatinolytic activity of MMPs (analysed by zymography) correlated with mRNA and western blot findings. Interestingly, visfatin significantly up-regulated VEGF receptor 2 expression. Inhibition of VEGFR2 and VEGF [by soluble FMS-like tyrosine kinase-1 (sFlt1)] down-regulated visfatin-induced MMP induction. Visfatin induced dose-and time-dependent proliferation and capillary-like tube formation. Importantly, visfatin was noted to have anti-apoptotic effects. In HUVECs, visfatin dose-dependently activated PI3K/Akt (phosphatidylinositol 3-kinase/Akt) and ERK1/2 (extracellular signal-regulated kinase) pathways. The functional effects and MMP/VEGF induction were shown to be dependent on the MAPK/PI3K-Akt/VEGF signalling pathways. Inhibition of PI3K/Akt and ERK1/2 pathways led to significant decrease of visfatin-induced MMP and VEGF production and activation, along with significant reduction in endothelial proliferation and capillary tube formation. Conclusion Our data provide the first evidence of visfatin-induced endothelial VEGF and AAMP production and activity. Further, we show for the first time the involvement of the MAPK and PI3K/Akt signalling pathways in mediating these actions, as welt as endothelial cell proliferation. Collectively, our findings provide novel insights into visfatin-induced endothelial angiogenesis.
引用
收藏
页码:356 / 365
页数:10
相关论文
共 45 条
[31]   Matrix metalloproteinases in cerebrovascular disease [J].
Mun-Bryce, S ;
Rosenberg, GA .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1998, 18 (11) :1163-1172
[32]   Kinetic analysis of the binding of human matrix metalloproteinase-2 and -9 to tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 [J].
Olson, MW ;
Gervasi, DC ;
Mobashery, S ;
Fridman, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (47) :29975-29983
[33]   A new mathematical model for relative quantification in real-time RT-PCR [J].
Pfaffl, MW .
NUCLEIC ACIDS RESEARCH, 2001, 29 (09) :E45
[34]  
Pollman MJ, 1999, J CELL PHYSIOL, V178, P359, DOI 10.1002/(SICI)1097-4652(199903)178:3<359::AID-JCP10>3.3.CO
[35]  
2-F
[36]   Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain [J].
Rosenberg, GA ;
Estrada, EY ;
Dencoff, JE .
STROKE, 1998, 29 (10) :2189-2195
[37]   CLONING AND CHARACTERIZATION OF THE CDNA-ENCODING A NOVEL HUMAN PRE-B-CELL COLONY-ENHANCING FACTOR [J].
SAMAL, B ;
SUN, YH ;
STEARNS, G ;
XIE, CS ;
SUGGS, S ;
MCNIECE, I .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (02) :1431-1437
[38]  
Shah P K, 2000, Cardiol Rev, V8, P31, DOI 10.1097/00045415-200008010-00007
[39]   Resistin, obesity, and insulin resistance - The emerging role of the adipocyte as an endocrine organ. [J].
Shuldiner, AR ;
Yang, RZ ;
Gong, DW .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (18) :1345-1346
[40]   Increased visfatin messenger ribonucleic acid and protein levels in adipose tissue and adipocytes in women with polycystic ovary syndrome: Parallel increase in plasma visfatin [J].
Tan, Bee K. ;
Chen, Jing ;
Digby, Janet E. ;
Keay, Stephen D. ;
Kennedy, C. Richard ;
Randeva, Harpal S. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (12) :5022-5028